Ubs Asset Management Americas Inc Cytek Biosciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 191,624 shares of CTKB stock, worth $640,024. This represents 0.0% of its overall portfolio holdings.
Number of Shares
191,624
Previous 197,058
2.76%
Holding current value
$640,024
Previous $1.28 Million
39.91%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CTKB
# of Institutions
160Shares Held
73.8MCall Options Held
600Put Options Held
4.9K-
Black Rock Inc. New York, NY17.1MShares$57 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.62MShares$32.1 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD7.46MShares$24.9 Million0.93% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$22.2 Million0.82% of portfolio
-
State Street Corp Boston, MA4.38MShares$14.6 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $450M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...